It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by jdub297
reply to post by generik
The "kid" was actually Atlanta attorney John Speaker, who traveled to Europe for his wedding and honeymoon.
Plane passengers sue TB patient
abcnews.go.com...
Although the CDC was aware of his diagnosis and plans, it did nothing to stop him from traveling abroad; contrary to some low-information members' misnformed rants.
jw
Originally posted by jdub297
reply to post by generik
No cites, no sources, no links, no references = BS.
Try harder.
business.inquirer.net...
PARIS — Scientists said Tuesday they had managed to kill lab-grown tuberculosis (TB) bacteria with good old Vitamin C — an “unexpected” discovery they hope will lead to better, cheaper drugs. A team from Albert Einstein College of Medicine in New York made the accidental find while researching how TB bacteria become resistant to the TB drug isoniazid. The researchers added isoniazid and a “reducing agent” known as cysteine to the TB in a test tube, expecting the bacteria to develop drug resistance. Instead, the team “ended up killing off the culture”, according to the study’s senior author William Jacobs, who said the result was “totally unexpected.” Reducing agents chemically reduce other substances. The team then replaced the cysteine in the experiment with another reducing agent — Vitamin C. It, too, killed the bacteria. “I was in disbelief,” said Jacobs of the outcome published in the journal Nature Communications. “Even more surprisingly… when we left out the TB drug isoniazid and just had Vitamin C alone, we discovered that Vitamin C kills tuberculosis.” The team next tested the vitamin on drug resistant strains of TB, with the same outcome. In the lab tests, the bacteria never developed resistance to Vitamin C — “almost like the dream drug”, Jacobs said in a video released by the college. He stressed the effect had only been demonstrated in a test tube so far, and “we don’t know if it will work in humans,” or which dose might be useful. “But in fact before this study we wouldn’t have even thought about trying this study in humans.”